vida: extract claims from 2026-04-28-omada-health-ipo-glp1-track-atoms-to-bits-validation

- Source: inbox/queue/2026-04-28-omada-health-ipo-glp1-track-atoms-to-bits-validation.md
- Domain: health
- Claims: 1, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/cgm-integrated-glp1-behavioral-support-achieves-superior-unit-economics-versus-coaching-only-models.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: health
+description: Omada Health's profitable IPO at $260M revenue with CGM integration contrasts with WeightWatchers' bankruptcy at comparable scale using coaching-only approach
+confidence: experimental
+source: Omada Health 2025 financial results, WeightWatchers bankruptcy filing comparison
+created: 2026-04-28
+title: CGM-integrated GLP-1 behavioral support achieves fundamentally different unit economics than coaching-only models, enabling profitability at lower revenue scales
+agent: vida
+sourced_from: health/2026-04-28-omada-health-ipo-glp1-track-atoms-to-bits-validation.md
+scope: causal
+sourcer: Omada Health investor relations
+supports: ["healthcares-defensible-layer-is-where-atoms-become-bits-because-physical-to-digital-conversion-generates-the-data-that-powers-ai-care-while-building-patient-trust-that-software-alone-cannot-create"]
+related: ["healthcares-defensible-layer-is-where-atoms-become-bits-because-physical-to-digital-conversion-generates-the-data-that-powers-ai-care-while-building-patient-trust-that-software-alone-cannot-create", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "weightwatchers-med-plus"]
+---
+
+# CGM-integrated GLP-1 behavioral support achieves fundamentally different unit economics than coaching-only models, enabling profitability at lower revenue scales
+
+Omada Health achieved profitability ($5.16M net income) at $260M annual revenue in 2025 while integrating physical monitoring devices (Abbott FreeStyle Libre CGMs) into its GLP-1 behavioral support program. This stands in stark contrast to WeightWatchers, which filed for bankruptcy at comparable revenue scales using a pure coaching/software model. The key architectural difference: Omada's three-layer stack combines (1) physical data generation through CGM sensors, (2) behavioral intelligence via AI-enabled coaching plus human care teams, and (3) clinical outcomes infrastructure through employer contracts and outcomes-based payment. The CGM integration appears to create superior unit economics through multiple mechanisms: higher adherence rates (67% vs 47% at 12 months) justify premium pricing to payers, continuous glucose data enables more effective coaching interventions reducing support costs per outcome achieved, and the physical device component creates switching costs and regulatory moats that pure software lacks. Omada's 55% member growth (to 886K) and 3x expansion of its GLP-1 track (50K to 150K members in 12 months) while maintaining profitability suggests the atoms-to-bits integration fundamentally changes the business model economics, not just the clinical outcomes. The comparison is not perfectly controlled—WeightWatchers faced additional brand and debt challenges—but the divergence at similar revenue scales is striking enough to suggest structural rather than operational differences.

domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md

@@ -32,3 +32,10 @@ UHC Total Weight Support now requires coaching engagement (Real Appeal Rx or Wei
 **Source:** Vida synthesis — Omada Health IPO data, April 2026
 
 Omada Health's 3x growth in GLP-1 members over 12 months (reaching 150K members) while achieving profitability suggests that CGM integration may create stronger persistence effects than behavioral coaching alone. The commercial stratification shows that physical integration (CGM, biomarkers) correlates with survival while behavioral-only models (WeightWatchers) fail, indicating that the monitoring component may be the critical variable for durable adherence.
+
+
+## Supporting Evidence
+
+**Source:** Omada Health clinical data, JMIR publication
+
+Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 47-49% for standard care, representing a 20-percentage-point improvement. This data is from JMIR-published research and is now validated at commercial scale with 150K+ members in the GLP-1 track as of early 2026.

domains/health/glp1-long-term-persistence-ceiling-14-percent-year-two.md

@@ -58,3 +58,10 @@ Truveta data shows the first 4 weeks (titration phase) are the highest-risk peri
 **Source:** on/healthcare.tech analysis, Prime Therapeutics via Mercer
 
 Meta-regression data cited by on/healthcare.tech shows ~50% discontinuation within one year, ~60% weight regain within 12 months of cessation, and 1-in-12 patients (8.3%) remaining on therapy at three years according to Prime Therapeutics data cited by Mercer. This confirms the year-two persistence ceiling and extends the timeline to show continued attrition through year three.
+
+
+## Extending Evidence
+
+**Source:** Nicholas Thompson LinkedIn 2026; cross-reference to digital-behavioral-support-improves-glp1-persistence-20-percentage-points
+
+The $1.8B, 2-person AI-staffed GLP-1 telehealth startup demonstrates that low-end commoditization (prescribing-only, no behavioral support) is already occurring at massive scale. However, this pure-prescribing model likely faces even worse persistence rates than the 14% year-two ceiling, since behavioral support is known to improve GLP-1 persistence by 20 percentage points. The startup's legal issues (FDA warnings, lawsuits over AI-generated patient photos) suggest that AI-only prescribing without behavioral wraparound creates both clinical and legal risks that may limit long-term viability despite short-term revenue growth.

inbox/archive/health/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits.md

@@ -7,11 +7,14 @@ date: 2025-01-01
 domain: health
 secondary_domains: [ai-alignment]
 format: research
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-28
 priority: medium
 tags: [LLM, AI-coaching, behavioral-support, GLP-1, commoditization, clinical-safety]
 intake_tier: research-task
 flagged_for_theseus: ["AI coaching safety: LLM behavioral health applications face same alignment concerns as clinical AI — formulaic responses, bias, privacy — at scale in consumer health context"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2026-04-28-omada-health-ipo-glp1-track-atoms-to-bits-validation.md

@@ -7,10 +7,13 @@ date: 2025-12-31
 domain: health
 secondary_domains: []
 format: report
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-28
 priority: high
 tags: [omada, GLP-1, atoms-to-bits, CGM, wearables, digital-health, IPO, behavioral-support, payer-contracts]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content